Serum neurofilament levels and patient-reported outcomes in multiple sclerosis.
Kristin GalettaChinmay DeshpandeBrian C HealyBonnie GlanzMarina ZiehnShrishti SaxenaAnu PaulFermisk SalehMikaela CollinsPatricia Gaitan-WalshPaola Castro-MendozaHoward L WeinerTanuja ChitinisPublished in: Annals of clinical and translational neurology (2021)
Serum NfL is a patient-centric biomarker that correlated with MS patient health-outcomes and healthcare utilization measures in a real-world cohort.